.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In June 2026, Proof concentrated 59.76% of sales in Tincture & Sublingual, where sales grew 8.42% year over year but fell 5.17% month over month, while Capsules held 22.06% share with an 11.90% YoY decline and a 1.58% MoM lift. Topical accounted for 10.38% share with a 0.27% YoY dip but a 26.22% MoM surge, and Concentrates at 7.46% share declined 54.11% YoY despite a 41.43% MoM rebound; Beverage contracted to 0.34% share with a 77.40% YoY drop and a 65.98% MoM decline. With overall brand sales down 7.69% YoY and average price up 8.10% YoY, the mix indicates reliance on a single core category and volatility at the edges, implying the brand’s growth path depends on stabilizing Tincture & Sublingual while converting the Topical and Concentrates MoM spikes into sustained share gains.
Proof’s rank at 7 in Tincture & Sublingual in California, alongside a 59.76% portfolio weight and a 5.17% MoM dip, signals concentration risk if category momentum softens, while the 26.22% MoM increase in Topical and the 41.43% MoM rise in Concentrates suggest near-term opportunities to diversify mix without sacrificing average price, which rose 8.10% YoY. Given Capsules’ 22.06% share paired with an 11.90% YoY decline, and Beverage’s 0.34% share with a 77.40% YoY fall, the pattern implies Proof’s positioning benefits from defending a top-10 anchor in Tincture & Sublingual while reallocating toward faster-recovering adjacencies to offset the brand’s 7.69% YoY sales contraction.
Competitive Landscape
Proof is ranked #7 in California Tincture & Sublingual for June 2026, improving 1 position from #8 year over year, while holding flat versus March 2026 at #7; this stability contrasts with ABX / AbsoluteXtracts rising from #7 to #5 and Papa & Barkley staying fixed at #1. Despite peaking at #6 in April 2026 before slipping back to #7, Proof’s relative position has inched ahead of last year as category leaders diverge—Yummi Karma holds #2 with a 3.27% sales YoY increase while Care By Design remains #3 with a -9.59% sales YoY change—implying Proof’s trajectory is one of incremental rank resilience anchored by marginal gains rather than breakout ascent.
Notable Products
CBD Extra Strength Tincture (1000mg CBD, 15ml) posted the steepest decline at -21.18% while dropping to rank 6, and High THC Tincture (1000mg THC, 15ml) fell -18.35% at rank 2. In contrast, CBD/THC 1:1 Balance Tincture (300mg CBD, 300mg THC, 15ml) climbed +32.32% at rank 3, and Indica Full Spectrum Oil Syringe (1g) rose +45.90% at rank 5. With eight of the top ten SKUs in Tincture & Sublingual, the mix indicates Proof is leaning toward fewer, higher-velocity tinctures punctuated by a single Concentrates riser to diversify risk.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
